دورية أكاديمية
Safety and efficacy of tofacitinib up to 48 months in patients with active psoriatic arthritis: final analysis of the OPAL Balance long-term extension study
| العنوان: | Safety and efficacy of tofacitinib up to 48 months in patients with active psoriatic arthritis: final analysis of the OPAL Balance long-term extension study |
|---|---|
| المؤلفون: | Nash, Peter, Coates, Laura C, Fleishaker, Dona *, Kivitz, Alan J, Mease, Philip J, Gladman, Dafna D, FitzGerald, Oliver, Wang, Cunshan, Wu, Joseph, Hsu, Ming-Ann, Menon, Sujatha, Fallon, Lara, Kanik, Keith S |
| المصدر: | In The Lancet Rheumatology April 2021 3(4):e270-e283 |
| قاعدة البيانات: | ScienceDirect |
| تدمد: | 26659913 |
|---|---|
| DOI: | 10.1016/S2665-9913(21)00010-2 |